The BCR-ABL fusion transcripts (b3a2 and b2a2) were analyzed in 41/62 CML patient samples using qualitative reverse transcriptase polymerase chain reaction (RT-PCR). This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.